Primary structure of matrilin-3, a new member of a family of extracellular matrix proteins related to cartilage matrix protein (matrilin-1) and von Willebrand factor
		1The nucleotide sequences reported in this paper have been submitted to the EMBL nucleotide sequence database with accession numbers Y10521 and Y13341.1  by Wagener, Raimund et al.
FEBS 19043 FEBS Letters 413 (1997) 129-134 
Primary structure of matrilin-3, a new member of a family 
of extracellular matrix proteins related to cartilage matrix protein 
(matrilin-1) and von Willebrand factor 
Raimund Wagener*, Birgit Kobbe, Mats Paulsson 
Institute for Biochemistry II, Medical Faculty, University of Cologne, Joseph-Stelzmann-Strasse 52, D-50931 Cologne, Germany 
Received 4 June 1997; revised version received 2 July 1997 
Abstract A mouse cDNA encoding for matrilin-3, the third 
member of the novel matrilin family of extracellular matrix 
proteins, was cloned. The protein precursor of 481 amino acids 
consists of a putative signal peptide, a short positively charged 
sequence, a single vWFA-like domain followed by four epidermal 
growth factor-like modules and a potential coiled-coil a-helical 
oligomerization domain at the C-terminus. It is the smallest 
member of the matrilin family with a predicted Mr of the mature 
protein of 48 902. The primary structure of a C-terminal portion 
of 310 amino acids of the human matrilin-3 was determined and 
showed a sequence identity to the mouse matrilin-3 of 84.8%. 
Northern blot hybridization of mouse matrilin-3 mRNA showed 
a 2.9 kb mRNA expressed in sternum, femur and trachea and 
indicates a cartilage-specific expression. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The multidomain structure is a common feature of many 
extracellular proteins [1] and approximately 50 different do-
mains have been identified in various animal proteins [2]. A 
unique protein is formed by the tandem arrangement of a 
certain set of domains. The protein superfamily containing 
the von Willebrand factor type A (vWFA)-like domain con-
sists of proteins with different domain organization and a 
variety of functions [3]. The vWFA-like domain was first de-
scribed in von Willebrand factor where it plays a key role in 
promoting platelet adhesion to the subendothelium. Several 
vWFA-like domains have been implicated in interactions 
with collagen [3]. 
Recently a new subfamily of extracellular matrix proteins 
with vWFA-like domains was defined — the matrilins. To 
date it consists of two members, cartilage matrix protein 
(CMP) now alternatively named matrilin-1 and the recently 
cloned matrilin-2 [4]. Matrilin-1 is a trimer of identical ellip-
soid subunits assembled via their C-terminal extension do-
mains in a coiled-coil a-helix [5]. Aggrecan [6,7] and type II 
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collagen-containing fibrils [8] have been proposed as binding 
partners for matrilin-1 and it has been suggested that matri-
lin-1 might play an integrating role in cartilage extracellular 
matrix organisation as a bridging molecule between these two 
major constituents [7]. It has also been shown that matrilin-1 
can form filamentous networks independent of collagen fibrils 
[9]. Matrilin-1 is expressed only in some types of the hyaline 
cartilage [10] whereas matrilin-2 is found in calvaria, uterus, 
heart, skeletal muscle, brain and skin but not in normal 
cartilage [4]. The expression patterns appear to be comple-
mentary. The primary structure of matrilin-1 has been de-
duced from chicken [11], man [12] and mouse [13] cDNA 
and that of matrilin-2 from mouse and partially from human 
cDNA [4]. In both cases the sequence is highly conserved 
between these species. The modular structure of the two is 
very similar with each containing two vWFA-like domains, 
interrupted by 1 or 10 EGF-like domains, respectively, and 
a C-terminal oligomerization domain. Matrilin-2 possesses an 
additional unique sequence of 75 amino acids between the 
second vWFA-like domain and the oligomerization unit and 
has a highly positively charged stretch of 16 amino acids con-
taining 6 arginine residues between the signal peptide and the 
first vWFA-like domain. It has been proposed from the struc-
tural homologies and the complementary sites of expression 
that these two matrilins may have a similar function in differ-
ent forms of extracellular matrix [4]. 
Supposing the existence of more members of this new fam-
ily of extracellular matrix proteins, we looked for gene prod-
ucts with a similar modular structure by searching in the EST 
databases. Here we report on the deduced primary structure 
of matrilin-3 from mouse, which is highly homologous to 
matrilin-1 and -2 and differs from both by lacking of the 
second vWFA-like domain. 
2. Materials and methods 
2.1. Clones and libraries 
The matrilin homologue human lung EST clone, IMAGE Consor-
tium Clone ID 119728 [14], was obtained from ATCC (#341513). An 
oligo(dT)- and random-primed lung cDNA library in lambda ZAP® 
II vector from 6-8-week-old female mice (B6CBA) was purchased 
from Stratagene. 
2.2. Screening of library and DNA sequencing 
2X 106 pfu were screened using a 1.1 kb N-terminal fragment of the 
human EST clone. The hybridization conditions were 5XSSPE 
(1XSSPE is 0.15 M NaCl, 10 mM sodium phosphate (pH 7.7) and 
1 mM EDTA), 5xDenhardt's solution (50xDenhardt's solution is 
1% BSA, 1% Ficoll 400 and 1% polyvinylpyrrolidone), 0.5% SDS, 
45% formamide and 20 ug/ml salmon sperm DNA at 42°C. Filters 
were washed in the last washing step with 0.1 XSSPE, 0.1% SDS for 
15 min at 55°C. The positive clone was in vivo excised yielding a 
cDNA clone in pBluescript SK(—). Using the dideoxy method and 
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GTCCTATGGCTGAGACCTCTGACCCTGTGTACCCCAGTTACCTCGCGGCTCACAGACCCCGGCAGGTCGTCAAGCCCATCATGTTGCTCT 90 
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CAGCCCCCTTACGCCACCTCCCGGGGCTTCTGCTGCTGCTCTGGCCGCTGTTGCTCCTGCCTTCCCTGGCTGCTCCTGGACGTTTGGCCC 1 8 0 
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T 
GCGCGAGCGTCCGCCGGCTGGGGACACGAGTCCCCGGAGGCAGCCCTGGGCATCTCTCTGCTCTGGCTACTTCCACCCGCGCGCCATATT 270 
A S v E g L G T E v P G G S P G H L S A L A T S T g A P Y S 64 
CCGGGGGCCGCGGCGCAGGTGTTTGCAAGAGCAGGCCTTTGGACTTGGTGTTCATCATTGATAGTTCTCGTAGCGTCCGGCCTCTGGAAT 3 60 
G G E G A G V C K S R P L D L V F I I D S S R S V R P L E F 94 
TCACCAAGGTGAAGACCTTTGTCTCCCGCATCATCGACACTCTGGACATCGGGGCCACAGACACGAGGGTGGCTGTGGTGAACTATGCCA 450 
T K V K T F V S R I I D T L D I G A T D T R V A V V N Y A S 124 
GCACTGTGAAGATAGAGTTCCAGCTCAACACCTATTCCGACAAGCAGGCCCTGAAACAGGCTGTGGCACGGATCACACCCTTGTCAACAG 5 40 
T V K I E F Q L N T Y S D K Q A L K Q A V A R I T P L S T G 154 
GCACCATGTCAGGGCTAGCTATCCAGACAGCGATGGAGGAAGCCTTCACTGTGGAGGCCGGGGCTCGGGGGCCCATGTCTAACATCCCCA 630 
T M S G L A I Q T A M E E A F T V E A G A R G P M S N I P K 184 
AGGTAGCTATTATCGTGACAGATGGGAGGCCGCAGGACCAGGTGAATGAGGTGGCTGCTCGAGCCCGTGCATCTGGCATTGAGCTGTATG 720 
V A I I V T D G R P Q D Q V N E V A A R A R A S G I E L Y A 214 
CTGTGGGTGTGGACCGGGCAGATATGGAGTCCCTCAAGATGATGGCTAGCAAGCCCCTGGAAGAGCACGTCTTCTACGTGGAGACCTACG 810 
V G V D R A D M E S L K M M A S K P L E E H V F Y V E T Y G 244 
GGGTCATTGAGAAGCTTTCTGCTAGATTCCAGGAAACCTTTTGTGCTCTGGATCAGTGCATGCTTGGCACACACCAGTGTCAGCACGTGT 900 
V I E K L S A R F Q E T F C A L D Q C M L G T H Q C Q H V C 274 
GTGTCAGCGATGGTGACGGCAAGCATCACTGCGAGTGCAGCCAAGGCTACACCTTGAACGCTGATGGGAAAACGTGTTCAGCCATTGATA 990 
V S D G D G K H H C E C S Q G Y T L N A D G K T C S A I D K 304 
AGTGTGCCCTTAGCACTCATGGATGTGAACAGATCTGTATCAACGACAGAAATGGCTCTTACCACTGCGAGTGCTATGGAGGTTACGCCT 1080 
C A L S T H G C E Q I C I N D R N G S Y H C E C Y G G Y A L 334 
TGAATGCAGACAGGAGAACGTGTGCAGCTCTGGACAAATGCGCCTCTGGTACACATGGTTGCCAGCACATCTGTGTGAATGATGGAGCCG 1170 
N A D R R T C A A L D K C A S G T H G C Q H I C V N D G A G 364 
GGTCCCATCACTGTGAATGTTTTGAAGGCTACACTCTGAATGCAGATAAGAAAACATGTTCAGTCCGGAACAAGTGTGCTCTAGGCACTC 12 60 
S H H C E C F E G Y T L N A D K K T C S V R N K C A L G T H 394 
ATGGCTGCCAGCACATCTGTGTGAGTGATGGAGCAGTGGCCTACCACTGTGACTGCTTCCCTGGCTACACCTTGAATGATGACAAGAAGA 1350 
G C Q H I C V S D G A V A Y H C D C F P G Y T L N D D K K T 424 
CATGTTCAGACATTGAAGAAGCCCGAAGCCTCATTTCCATAGAAGACGCCTGCGGCTGTGGGGCCACGCTGGCATTCCAGGAGAAGGTCA 14 4 0 
C S D I E E A R S L I S I E D A C G C G A T L A F Q E K V S 454 
GCTCCCATCTCCAGAAGCTGAACACCAAACTTGACAACATTTTGAAGAAGTTGAAAGTAACAGAATATGGACAAGTACATCGTTAAACTG 1530 
S H L Q K L N T K L D N I L K K L K V T E Y G Q V H R * 481 
TGTAAAACTCTCGCCTGGAAATGTGGAGGGCTTGATATATGCGATTCTCATTCTCTTGTCACGCTATCTGATGTGCCTGCTAATAATCTG 1620 
CCATTATAAATGCTTAACATTATTTGGTAAACAGTGTGAGGGGTTTCTGGAGAACCATATTGTTTTCCAAGGAGATAAATGTGTAGACCC 1710 
TTATTAAAAGCAAGTTTAATGTCTCATAGCTATGACTGTGAAATCATTAATAAGATAGAGAGTGAAAAGTTTAAGGTTTTGTTATCTACT 1800 
GTTTGAGCCATTTAAGTTTAAATTGTTTATATTAGTAAGATGATCTTACTCATAAAACTTTAGGTCTATTTTCTCTTGGTCATATTTATA 18 90 
ATACGAACCAGCCTTACTACCAAGAGTGCAAATTTTATGAAATATTTACACATAC 1945 
B 
GGAGGCAGGGGCTCGAGAGCCCTCTTCTAACATCCCTAAGGTGGCCATCATTGTTACAGATGGGAGGCCCCAGGACCAGGTGAATGAGGT 90 
E A G A R E P S S N I P K V A I I V T D G R P Q D Q V N E V 30 
GGCGGCTCGGGCCCAAGCATCTGGTATTGAGCTCTATGCTGTGGGCGTGGACCGGGCAGACATGGCGTCCCTCAAGATGATGGCCAGTGA 180 
A A R A Q A S G I E L Y A V G V D R A D M A S L K M M A S E 60 
GCCCCTAGAGGAGCATGTTTTCTACGTGGAGACCTATGGGGTCATTGAGAAACTTTCCTCTAGATTCCAGGAAACCTTCTGTGCGCTGGA 270 
P L E E H V F Y V E T Y G V I E K L S S R F Q E T F C A L D 90 
CCCCTGTGTGCTTGGAACACACCAGTGCCAGCACGTCTGCATCAGTGATGGGGAAGGCAAGCACCACTGTGAGTGTAGCCAAGGATACAC 3 60 
P C V L G T H Q C Q H V C I S D G E G K H H C E C S Q G Y T 120 
CTTGAATGCCGACAAGAAAACGTGTTCAGCTCTTGATAGGTGTGCTCTTAACACCCACGGATGTGAGCACATCTGTGTGAATGACAGAAG 450 
L N A D K K T C S A L D R C A L N T H G C E H I C V N D R S 150 
TGGCTCTTATCATTGTGAGTGCTATGAAGGTTATACCTTGAATGAAGACAGGAAAACTTGTTCAGCTCAAGATAAATGTGCTTTGGGTAC 540 
G S Y H C E C Y E G Y T L N E D R K T C S A Q D K C A L G T 180 
CCATGGGTGTCAGCACATTTGTGTGAATGACAGAACAGGGTCCCATCATTGTGAATGCTATGAGGGCTACACTCTGAATGCAGATAAAAA 630 
H G C Q H I C V N D R T G S H H C E C Y E G Y T L N A D K K 210 
AACATGTTCAGTCCGTGACAAGTGTGCCCTAGGCTCTCATGGTTGCCAGCACATTTGTGTGAGTGATGGGGCCGCATCCTACCACTGTGA 720 
T C S V R D K C A L G S H G C Q H I C V S D G A A S Y H C D 240 
TTGCTATCCTGGCTACACCTTAAATGAGGACAAGAAAACATGTTCAGCCACTGAGGAAGCACGAAGACTTGTTTCCACTGAAGATGCTTG 810 
C Y P G Y T L N E D K K T C S A T E E A R R L V S T E D A C 270 
TGGATGTGAAGCTACACTGGCATTCCAGGACAAGGTCAGCTCGTATCTTCAAAGACTGAACACTAAACTTGATGACATTTTGGAGAAGTT 900 
G C E A T L A F Q D K V S S Y L Q R L N T K L D D I L E K L 300 
GAAAATAAATGAATATGGACAAATACATCGTTAAATTGCTCCAATTTCTCACCTGAAAATGTGGACAGCTTGGTGTACTTAATACTCATG 9 90 
K I N E Y G Q I H R * 310 
CATTCTTTTGCACACCTGTTATTGCCAATGTTCCTGCTAATAATTTGCCATTATCTGTATTAATGCTTGAATATTACTGGATAAATTGTA 1080 
TGAAGATCTTCTGCAGAATCAGCATGATTCTTCCAAGGAAATACATATGCAGATACTTATTAAGAGCAAACTTTAGTGTCTCTAAGTTAT 1170 
GACTGTGAAATGATTGGTAGGAAATAGAATGAAAAGTTTAGTGTTTCTTTATCTACTAATTGAGCCATTTAATTTTTAAATGTTTATATT 12 60 
AGATAACCATATTCACAATGGAAACTTTAGGTCTAGTTTCTTTTGATAGTATTTATAATATAAATCAATCTTATTACTGAGAGTGCAAAT 1350 
TGTACAAGGTATTTACACATAC 1372 
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Fig. 1. Nucleotide and deduced amino acid sequences of matrilin-3. A: Complete sequence of mouse matrilin-3 precursor. Arrowhead: Pre-
dicted propeptidase cleavage site. Arginine residues at the amino terminus of the protein are shaded black. The predicted O-glycosylation sites 
(amino acid residues 58, 59, 153, 163 and 170) are underlined once, the potential N-linked glycosylation site (amino acid residues 321-323) is 
underlined twice. B: Partial nucleotide and amino acid sequence of human matrilin-3. 
an ALF automatic sequencer (Pharmacia) the plasmids were se-
quenced in both directions with universal and internal primers. Nu-
cleotide sequence analysis was performed with the programs of the 
GCG package [15]. 
2.3. Northern blot analysis 
Total RNA of various tissues was extracted from 4-week-old female 
mice by the guanidinium-thiocyanate method. Poly(A+) RNA was 
prepared from the total RNA using the Pharmacia mRNA kit. Ali-
quots (3-6 ug) of poly(A+) RNA were electrophoresed on 1.2% de-
naturing agarose gel, blotted and hybridized. The conditions for the 
last washing step were: 0.1XSSPE, 0.1% SDS at 65°C for 15 min. 
3. Results 
A search in the EST database yielded an EST from human 
lung (T94707) with a sequence identity to the C-terminal part 
of the N-terminal vWFA-like domains of matrilin-1 and -2 of 
59.8% and 48.3%, respectively. We sequenced the EST clone 
and found an open reading frame (ORF) of 310 amino acids 
(Fig. IB). The clone was incomplete, starting within a vWFA-
like domain followed by four EGF-like domains and a puta-
tive coiled-coil oc-helical domain (Fig. 2). From the striking 
homologies to the other matrilins we concluded that we had 
found a new member of the matrilin family. From this point 
onwards the work was continued in the mouse. To get the 
complete sequence we screened a mouse lung cDNA library 
with the human clone as a probe. We isolated a clone that 
contained an ORF of 1443 bp ending with a TAA-stop codon 
preceded by a 80 bp long 5'-untranslated region (Fig. 1A) 
with a sequence identity to the human EST of 84.8% on the 
protein level indicating that it codes for the mouse homo-
logue. The nucleotide sequence codes for a protein precursor 
of 481 amino acids with a putative signal peptide of 27 amino 
acids as predicted by a method using neural networks [16]. An 
in frame ATG codon is found further upstream which, if used, 
would yield a 25 residue longer signal peptide. However, this 
would result in an unusual signal peptide sequence followed 
by a classical signal peptide. The mature secreted protein has 
a predicted Mr of 48902 and is to date the least complex 
member of the matrilin family (Fig. 2). It contains only one 
vWFA-like domain followed by four EGF-like domains and a 
putative oligomerization domain. N-terminal to the vWFA-
like domain is a positively charged sequence of about 40 ami-
no acid residues with a high content of arginine. The second 
EGF-like domain of the mouse matrilin-3 contains one poten-
tial N-glycosylation site (Asn321-Gly-Ser) which is, however, 
lacking in the partial human sequence. By using a neural net-
works prediction method [17] we found two potential O-gly-
cosylation sites in the positively charged sequence and three in 
the vWFA-like module of mouse matrilin-3 (Fig. 1A). The 
corresponding sequence of the human matrilin-3 has not 
been determined. 
A sequence alignment of the different modules with their 
counterparts in the other matrilins shows the striking homol-
ogy (Fig. 3). The sequence identity to the first vWFA-like 
domains of mouse matrilin-1 and -2 is 58.5% and 49.7%, 
respectively, and for the second vWFA-like domain 37.8% 
and 41.2%o. The metal ion-dependent adhesion site (MIDAS) 
motif [18], the 2 flanking cysteine residues and the 6 hydro-
phobic residues that are highly conserved in vWFA-like do-
mains [19] are also conserved in matrilin-3. The structure con-
sists of alternating amphipatic oc-helices and hydrophobic 
p-strands (Fig. 3A) and is in good agreement with the struc-
ture of the vWFA-like domain of the oc-subunit of the A do-
main of the integrin CR3 which has been determined at high 
resolution [18]. The EGF-like domains, which are character-
ized by the spacing of 6 cysteines, have an average sequence 
identity of 50.3% to the EGF-like domain of matrilin-1 and 
range between 55%> for the third and 47.5%> for the second 
EGF-like domain. Comparing the EGF-like domains of ma-
trilin-2 and -3, the identity is highest (61.5%>) between the 
third EGF-like domain of matrilin-3 and the third EGF-like 
domain of matrilin-2 and lowest (36.6%o) between the fourth 
EGF-like domain of matrilin-3 and seventh EGF-like domain 
of matrilin-2. The average sequence identity is 46%. The EGF-
like domains of matrilin-3 all have an additional asparagine 
3 residues C-terminal of the third cysteine residue and lack the 
key residues involved in Ca2+ binding to EGF-like domains 
(Fig. 3B). The potential oligomerization domain has the low-
est homology to the other matrilins (Fig. 3C). While the de-
gree of identity is 38.1% to matrilin-1 and only 21.7% to 
matrilin-2 the positions 'a' and 'd' of the heptad repeats are 
well conserved. The COILS program [20] detects one heptad 
repeat less than in the other matrilins. A threonine residue 
instead of a hydrophobic amino acid is found at the 'd' posi-
tion at the beginning and at the end of the coiled-coil domain. 
The pair of closely spaced cysteine residues at the beginning of 
the oligomerization domain is conserved in all three matrilins. 
In the case of matrilin-1 it was shown that these cysteines 
form interchain disulfide bonds [21]. 
We studied the expression of the matrilin-3 gene in different 
mouse tissues by Northern hybridization with poly(A+) RNA. 
A 2.9 kb band was detected in sternum, femur and very 
weakly also in trachea. Other tissues tested were negative 
(Fig. 4). 
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Fig. 2. Comparison of the modular structure of the matrilin family. 
The horizontal line denotes the coding region of the incomplete hu-
man matrilin-3 cDNA clone (ID 119728) [14]. 
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4. Discussion 
We have isolated and characterized a cDNA for matrilin-3, 
the third member of a novel family of extracellular matrix 
proteins, as evidenced from the striking sequence similarity 
of the protein to the other two members which are the nearest 
homologues detected in the databases. Matrilin-3 shares the 
modular composition of vWFA-like, EGF-like and coiled-coil 
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Fig. 3. Amino acid sequence alignments of the matrilin modules. Murine sequences were aligned by the PILEUP program of the GCG pack-
age, using the default parameters. Matrilin-1 (CMP) [13] is numbered from the first codon identified, matrilin-2 [4] and -3 are numbered from 
the first amino acid of the protein precursor. A: Sequence alignment of the vWFA-like modules. The locations of the oc-helices and (5-sheets de-
termined from averaged structure predictions of 75 modules [19] are indicated by the arrow ranges |31-al2. Structure predictions by the Chou-
Fasman and Gamier methods for the vWFA-like module of matrilin-3 are shown underneath (b, (3-sheet; a, a-helix; t, turn). The conserved 
metal ion-dependent adhesion site [18] and the conserved hydrophobic moieties [19] are denoted with (■) or (*) respectively. B: Sequence align-
ment of the EGF-like modules. The conserved positions of the cysteine residues are marked by asterisks; the additional aspartic acid residue of 
the matrilin-3 EGF-like repeats is marked by an arrow. C: Sequence alignment of the a-helical coiled-coil domains. The positions a and d of 
the heptad repeats are indicated above. The conserved cysteine residues at the N-terminal end of the coiled-coil region are marked with arrows. 
domains. Although there are strong homologies between ma-
trilin-3 and the previously known matrilins there are clear 
differences in the domain arrangement. The expression of 
the gene is restricted to cartilage and appears similar to the 
expression pattern of matrilin-1 (CMP). 
A comparison of the EGF-like repeats of matrilin-3 with 
those of matrilin-1 and -2 also shows a remarkable difference 
in the presence of an additional aspartic acid residue in each 
EGF-like domain of matrilin-3 (Fig. 3C). From the 3-dimen-
sional structure of a pair of EGF-like domains of fibrillin [22] 
it can be inferred that the aspartic acid residue would be 
positioned in the second loop with its side chain exposed to 
the solvent potentially allowing ligand interactions. The con-
servation of the MIDAS motif [18] in the vWFA-like domain 
implies the dependence on divalent cations for function. The 
presence of heptad repeats indicates the oligomerization of 
subunits via a coiled-coil a-helical structure. The number of 
subunits in the oligomer cannot be predicted from the se-
quence alone. It was recently demonstrated that the exchange 
of a single amino acid residue in the coiled-coil domain of 
matrilin-1 leads to the assembly of a tetramer instead of a 
trimer [23]. 
The differences between the domain compositions of matri-
lin-1, -2 and -3 must have implications for their functions. 
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Fig. 4. Distribution of matrilin-3 mRNA in various mouse tissues. 
Northern hybridization of 3-6 ug poly(A+) RNA from 4-week-old 
mice. The blot was hybridized with a 500 bp fragment of the coding 
region of matrilin-3 cDNA (upper part) and subsequently with a 
GAPDH cDNA fragment (lower part) to estimate the relative abun-
dance of the matrilin-3 message. The signal in the lane for lungs is 
due to an artifact. The exposure times for the autoradiography were 
12 h using a phosphor imager (Molecular Dynamics). 
There is evidence for the binding of matrilin-1 not only to 
aggrecan [6,7] but also to collagen type II [8]. By use of trun-
cated forms of recombinant matrilin-1 (CMP) it was shown 
that a binding site involved in assembly into both the colla-
genous and the non-collagenous fibrils is located in the NH2-
terminal portion of the protein [9]. Matrilin-2 has not yet been 
studied in this respect. The functions or the potential binding 
partners of the second vWFA-like domains in matrilin-1 and 
-2 are not known and it is therefore not possible to make 
suggestions by analogy about the consequences of the lack 
of this domain in matrilin-3. Based on the extent of sequence 
identity it could be that the sites for matrix binding are lo-
cated on the single vWFA-like domain of matrilin-3 and that 
a functional difference between matrilin-3 and the matrilins-1 
and -2 depends on the unknown function of the lacking 
vWFA-like domain. 
The apparently cartilage-specific expression of matrilin-3 
mRNA is analogous to that of matrilin-1. Matrilin-3 
mRNA is not detected in matrilin-2 expressing tissues. 
Although both matrilin-3 cDNA clones described here were 
derived from lung cDNA libraries we could not detect matri-
lin-3 RNA in lung tissue. As we have found expression in 
trachea this apparent discrepancy could be due to a cartilage 
contamination of the lung tissue from which the libraries were 
prepared or to that the expression level in lung is too low for 
a detection with Northern hybridization. 
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